Close



Apr 4, 2024 08:35AM
Apr 4, 2024 08:30AM
Feb 29, 2024 07:30AM
Jan 8, 2024 07:36AM
Jan 8, 2024 07:30AM
Nov 7, 2023 07:30AM
Nov 7, 2023 07:15AM Arbutus Biopharma (ABUS) Announces CEO, William Collier, to Retire December 31
Nov 7, 2023 07:15AM
Oct 11, 2023 08:05AM
Sep 11, 2023 04:15PM
Aug 3, 2023 07:30AM
May 4, 2023 07:30AM
Apr 25, 2023 07:30AM
Apr 25, 2023 07:30AM Arbutus Announces FDA Clinical Hold on IND Application for AB-101, an oral PD-L1 inhibitor
Apr 25, 2023 07:30AM
Feb 28, 2022 09:30AM
Nov 4, 2021 07:30AM
Nov 4, 2021 07:30AM
Aug 5, 2021 07:30AM
Aug 5, 2021 07:30AM
Jul 7, 2021 07:00AM Arbutus Biopharma (ABUS) Receives Authorization to Proceed with IND for AB-729, its Proprietary Subcutaneously-Delivered RNAi Agent
Jul 7, 2021 07:00AM
Jul 7, 2021 07:00AM
Dec 17, 2020 09:22AM
May 11, 2020 09:28AM
Feb 10, 2020 09:21AM
Aug 5, 2019 07:30AM
Aug 5, 2019 07:30AM Arbutus Reports Second Quarter 2019 Financial Results and Provides Corporate Update
Jul 2, 2019 04:03PM
Jul 2, 2019 04:01PM
Jul 2, 2019 04:01PM
May 6, 2019 04:01PM
May 6, 2019 04:01PM
Mar 7, 2019 04:01PM
Mar 7, 2019 04:01PM Arbutus Reports Fourth Quarter and Year-end 2018 Financial Results and Describes Recent Clinical Accomplishments and Key 2019 Objectives
Nov 7, 2018 04:01PM
Nov 7, 2018 04:01PM
Aug 13, 2018 08:33AM
Aug 13, 2018 08:30AM
Aug 13, 2018 08:30AM
Aug 2, 2018 04:00PM
Aug 2, 2018 04:00PM Arbutus Reports 2018 Second Quarter Financial Results and Provides Corporate Update
Jul 10, 2018 07:00AM
Jul 10, 2018 07:00AM
Mar 15, 2018 09:27AM
Mar 14, 2018 04:00PM
Mar 14, 2018 04:00PM
Nov 16, 2017 01:40PM
Nov 2, 2017 04:00PM Arbutus Announces Corporate Update and Third Quarter 2017 Financial Results
Oct 2, 2017 09:32AM

251,639 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All